These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 25425686)

  • 1. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
    Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
    Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model.
    Schmidt PJ; Fitzgerald K; Butler JS; Fleming MD
    Am J Hematol; 2021 Feb; 96(2):251-257. PubMed ID: 33180328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
    Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD
    Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia.
    De Franceschi L; Daraio F; Filippini A; Carturan S; Muchitsch EM; Roetto A; Camaschella C
    Haematologica; 2006 Oct; 91(10):1336-42. PubMed ID: 17018382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
    Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
    Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HJV and HFE Play Distinct Roles in Regulating Hepcidin.
    Wu Q; Wang H; An P; Tao Y; Deng J; Zhang Z; Shen Y; Chen C; Min J; Wang F
    Antioxid Redox Signal; 2015 May; 22(15):1325-36. PubMed ID: 25608116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin.
    Kent P; Wilkinson N; Constante M; Fillebeen C; Gkouvatsos K; Wagner J; Buffler M; Becker C; Schümann K; Santos MM; Pantopoulos K
    J Mol Med (Berl); 2015 May; 93(5):489-98. PubMed ID: 25609138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of iron homeostasis by hepatocyte TfR1 requires HFE and contributes to hepcidin suppression in β-thalassemia.
    Xiao X; Moschetta GA; Xu Y; Fisher AL; Alfaro-Magallanes VM; Dev S; Wang CY; Babitt JL
    Blood; 2023 Jan; 141(4):422-432. PubMed ID: 36322932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?
    Rausa M; Pagani A; Nai A; Campanella A; Gilberti ME; Apostoli P; Camaschella C; Silvestri L
    PLoS One; 2015; 10(4):e0122696. PubMed ID: 25860887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of erythroferrone as an erythroid regulator of iron metabolism.
    Kautz L; Jung G; Valore EV; Rivella S; Nemeth E; Ganz T
    Nat Genet; 2014 Jul; 46(7):678-84. PubMed ID: 24880340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
    Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
    Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.
    Finberg KE; Whittlesey RL; Fleming MD; Andrews NC
    Blood; 2010 May; 115(18):3817-26. PubMed ID: 20200349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron and hepcidin: a story of recycling and balance.
    Camaschella C
    Hematology Am Soc Hematol Educ Program; 2013; 2013():1-8. PubMed ID: 24319154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.
    Wallace DF; Summerville L; Crampton EM; Frazer DM; Anderson GJ; Subramaniam VN
    Hepatology; 2009 Dec; 50(6):1992-2000. PubMed ID: 19824072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystathionine β-synthase is required for body iron homeostasis.
    Zhou YF; Wu XM; Zhou G; Mu MD; Zhang FL; Li FM; Qian C; Du F; Yung WH; Qian ZM; Ke Y
    Hepatology; 2018 Jan; 67(1):21-35. PubMed ID: 28859237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.
    Delima RD; Chua AC; Tirnitz-Parker JE; Gan EK; Croft KD; Graham RM; Olynyk JK; Trinder D
    Hepatology; 2012 Aug; 56(2):585-93. PubMed ID: 22383097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted hepcidin response to inflammation in the absence of Hfe and transferrin receptor 2.
    Wallace DF; McDonald CJ; Ostini L; Subramaniam VN
    Blood; 2011 Mar; 117(10):2960-6. PubMed ID: 21245482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload.
    Schwartz AJ; Das NK; Ramakrishnan SK; Jain C; Jurkovic MT; Wu J; Nemeth E; Lakhal-Littleton S; Colacino JA; Shah YM
    J Clin Invest; 2019 Jan; 129(1):336-348. PubMed ID: 30352047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.